IMMUNOCELLULAR THERAPEUTICS's ticker is and the CUSIP is 452536955. A total of 1 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 300 | -94.0% | 0.00% | – |
| Q3 2014 | $4,000 | -87.9% | 5,000 | -82.9% | 0.00% | -100.0% |
| Q2 2014 | $33,000 | -57.1% | 29,200 | -53.5% | 0.00% | 0.0% |
| Q1 2014 | $77,000 | -60.5% | 62,800 | -70.2% | 0.00% | -66.7% |
| Q4 2013 | $195,000 | -54.7% | 210,900 | +26.0% | 0.00% | -62.5% |
| Q3 2013 | $430,000 | +72.7% | 167,400 | +30.3% | 0.01% | +33.3% |
| Q2 2013 | $249,000 | – | 128,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 128,500 | $249,000 | 0.01% |